We thus propose Atrogin1 and MuRF1 as FSHD markers, although it is not clear whether the Atrogin1 and MuRF1 genes are direct DUX4 transcriptional targets or are further down in the activation cascade. This evidence concerns the gene FBXO32 and facioscapulohumeral muscular dystrophy.